Description: Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for th
Learn about our Legal and IP Division’s DEI commitment and impact Read More Astellas Pledges to End Cancer Stigma in the Workplace Read More Learn more about how Astellas is prioritizing treatments to support women's health Read More Learn more about our clinical trials and educational resources on the clinical trial process. Read More 1 2 3 4 News Press Releases News / Press Releases Jan 08, 2025 U.S. FDA Confirms Class 1 Resubmission of the Supplemental New Drug Application for IZERVAY™ (avacincaptad pego
Learn more about our commitment to patients and available resources